MiR-205 and miR-200c: Predictive micro RNAs for lymph node metastasis in triple negative breast cancer

Journal of Breast Cancer

Volumn 17, Issue 2, 2014, Pages 143-148

  Berber, Ufuk ^a   Yilmaz, Ismail ^a   Narli, Gizem ^a   Haholu, Aptullah ^a   Kucukodaci, Zafer ^a   Demirel, Dilaver ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Breast; Carcinoma; Micro RNAs

Indexed keywords

MICRORNA 100; MICRORNA 122; MICRORNA 155; MICRORNA 200; MICRORNA 200C; MICRORNA 205; MICRORNA 31; MICRORNA 9;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MIDDLE AGED; MRNA EXPRESSION ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TRIPLE NEGATIVE BREAST CANCER; UPREGULATION;

EID: 84903955805     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2014.17.2.143     Document Type: Article

References (19)

1. Fabian MR, Sonenberg N. Te mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol 2012; 19:586-93.
2. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006;103:2257-61.
3. Tang J, Ahmad A, Sarkar FH. Te role of microRNAs in breast cancer migration, i{dotless}nvasion and metastasis. Int J Mol Sci 2012;13:13414-37.
4. Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007; 25:5287-312.
5. Dawson SJ, Provenzano E, Caldas C. Triple negative breast cancers: clinical and prognostic implications. Eur J Cancer 2009;45 Suppl 1:27-40.
6. Rakha EA, Reis-Filho JS, Ellis IO. Basal-like breast cancer: a critical review. J Clin Oncol 2008;26:2568-81.
7. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8.
8. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szász AM, Wang ZC, et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009;137:1032-46.
9. Augoff K, McCue B, Plow EF, Sossey-Alaoui K. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethyl-ation in triple-negative breast cancer. Mol Cancer 2012;11:5.
10. Wu H, Zhu S, Mo YY. Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res 2009;19:439-48.
11. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, et al. Te miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008;10:593-601.
12. Radojicic J, Zaravinos A, Vrekoussis T, Kafousi M, Spandidos DA, Stathopoulos EN. MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer. Cell Cycle 2011;10:507-17.
13. Savad S, Mehdipour P, Miryounesi M, Shirkoohi R, Fereidooni F, Man-souri F, et al. Expression analysis of MiR-21, MiR-205, and MiR-342 in breast cancer in Iran. Asian Pac J Cancer Prev 2012;13:873-7.
14. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009;11:1487-95.
15. Wu X, Somlo G, Yu Y, Palomares MR, Li AX, Zhou W, et al. De novo sequencing of circulating miRNAs identifes novel markers predicting clinical outcome of locally advanced breast cancer. J Transl Med 2012; 10:42.
16. Roth C, Rack B, Müller V, Janni W, Pantel K, Schwarzenbach H. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 2010;12:R90.
17. Lee JA, Lee HY, Lee ES, Kim I, Bae JW. Prognostic implications of mi-croRNA-21 overexpression in i{dotless}nvasive ductal carcinomas of the breast. J Breast Cancer 2011;14:269-75.
18. Ouzounova M, Vuong T, Ancey PB, Ferrand M, Durand G, Le-Calvez Kelm F, et al. MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells. BMC Genomics 2013;14:139.
19. Zeng RC, Zhang W, Yan XQ, Ye ZQ, Chen ED, Huang D P, et al. Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer. Med Oncol 2013;30:477.